x |
ANNUAL
REPORT UNDER SECTION 13 OR 15(d) OF
THE
|
o |
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF
THE
|
Simtrol,
Inc.
|
||||
(Name
of
small business issuer in its
charter)
|
Delaware
|
58-2028246
|
(State
or
other jurisdiction of
incorporation or organization) |
(I.R.S.
Employer
Identification
No.)
|
520
Guthridge Court, Suite 250, Norcross, Georgia
30092
|
||||
(Address
of
principal executive offices) (Zip Code)
|
||||
Issuer’s
telephone number: (770)
242-7566
|
· |
The
convertible notes are unsecured, bear interest at the rate of 12%
per
annum, are payable six months from the issue date (“Maturity Date”) and
can be pre-paid at any time without penalty.
|
· |
If
Simtrol
closes a “Qualifying Next Equity Financing” (as defined below) before the
Maturity Date, the then-outstanding balance of principal and accrued
interest on the convertible notes will automatically convert into
shares
of the “Next Equity Financing Securities” (as defined below) we issue. A
“Qualifying Next Equity Financing” means the first bona fide equity
financing (or series of related equity financing transactions) occurring
subsequent to the date of issue of a Convertible Note in which we
sell and
issue any of our securities for total consideration of not less than
$2.0
million in the aggregate (including the principal balance and accrued
but
unpaid interest to be converted on all our outstanding convertible
notes)
at a price per share for equivalent shares of Common Stock that is
not
greater than $0.75 per share. “Next Equity Financing Securities” means the
type and class of equity securities that we sell in a Qualifying
Next
Equity Financing or a Non-Qualifying Next Equity Financing. If we
sell a
unit comprised of a combination of equity securities, then the Next
Equity
Financing Securities shall be deemed to constitute that unit.
|
· |
If
we close a
“Non-Qualifying Next Equity Financing” (as defined below) before the
Maturity Date, the then-outstanding balance of principal and accrued
interest on the convertible notes can be converted, at the option
and
election of the investor, into shares of the “Next Equity Financing
Securities” we issue. A “Non-Qualifying Next Equity Financing” means that
we complete a bona fide equity financing but we fail to raise total
consideration of at least $2.0 million, or the price per share for
equivalent shares of Common Stock is greater than $0.75 per share.
|
· |
Upon
conversion of a Convertible Note, we will issue that number of shares
of
Next Equity Financing Securities equal to the quotient obtained by
dividing the then outstanding balance of principal and accrued interest
on
the convertible notes by the price per share of the Next Equity Financing
Securities.
|
· |
Upon
any
default, we would be required to pay a 1% default fee on the outstanding
balance. The default fee will be added to the outstanding balance
and
become due under the terms of the Convertible Note.
|
|
HIGH
|
LOW
|
|||||
FISCAL
YEAR
ENDED DECEMBER 31, 2006
|
|||||||
First
Quarter
|
$
|
1.25
|
$
|
0.51
|
|||
Second
Quarter
|
0.75
|
0.36
|
|||||
Third
Quarter
|
0.90
|
0.25
|
|||||
Fourth
Quarter
|
0.51
|
0.25
|
|||||
FISCAL
YEAR
ENDED DECEMBER 31, 2007
|
|||||||
First
Quarter
|
$
|
2.80
|
$
|
0.27
|
|||
Second
Quarter
|
2.25
|
1.01
|
|||||
Third
Quarter
|
1.55
|
0.90
|
|||||
Fourth
Quarter
|
1.30
|
0.60
|
Plan
category
|
Number
of
securities to be issued upon exercise of outstanding options, warrants
and
rights
(a)
|
Weighted-average
exercise price of outstanding options, warrants and rights
(b)
|
Number
of
securities remaining available for future issuance under equity
compensation plans (excluding securities reflected in column
(a)
(c)
|
|||
Equity
compensation plans approved by
security
holders
|
4,401,375
|
$0.94
|
1,598,625
|
|||
Equity
compensation plans not approved
by
security holders
|
16,434,774
|
$0.60
|
-
|
|||
Total
|
20,836,149
|
$0.67
|
1,598,625
|
·
|
Revenue
recognition.
We
follow the
guidance of the Securities and Exchange Commission’s Staff Accounting
Bulletin 104 for revenue recognition. In general, we record revenue
when
persuasive evidence of an arrangement exists or product delivery
has
occurred or services rendered, the sales price to the customer is
fixed
and determinable, and collectability is reasonably assured. Certain
judgments affect the application of our revenue policy. Revenue consists
of the sale of device control software and related maintenance contracts
on these systems. Revenue on the sale of hardware is recognized upon
shipment. We recognize revenue from OnGoer software sales upon shipment
as
we sell the product to audiovisual integrators, net of estimated
returns
and discounts. Revenue on maintenance contracts is recognized over
the
term of the related contract.
|
·
|
Capitalized
software research and development costs.
Our policy
on capitalized software costs determines the timing of our recognition
of
certain development costs. In addition, this policy determines whether
the
cost is classified as development expense or is capitalized. Software
development costs incurred after technological feasibility has been
established are capitalized and amortized, commencing with product
release, using the greater of the income forecast method or on a
straight-line basis over the useful life of the product. Management
is
required to use professional judgment in determining whether development
costs meet the criteria for immediate expense or capitalization.
The
Company did not capitalize any software development costs during
either
2007 or 2006 and all assets were fully amortized by December 31,
2006.
Total capitalized software costs are $2,208,070 and all amounts were
previously amortized.
|
· |
Impairment
of Assets/Investments.
We record
impairment losses on assets and investments when events and circumstances
indicate that the assets might be impaired and the undiscounted cash
flows
estimated to be generated by those assets are less than the carrying
amount of those items. Our cash flow estimates are based on historical
results adjusted to reflect our best estimate of future market and
operating conditions. The net carrying value of assets not recoverable
is
reduced to fair value. Our estimates of fair value represent our
best
estimate based on industry trends and reference to market rates and
transactions. No impairment was recorded in 2007 or
2006.
|
· |
Stock-Based
Compensation.
Stock option
awards are granted with an exercise price equal to or greater than
the
market price of our stock on the date of the grant in accordance
with the
our 2002 Equity Incentive Plan. The options generally have five-year
contractual terms for directors and 10 years for employees, and vest
immediately for directors and over four years for employees. The
Company
implemented FAS 123R in the first quarter of 2006. The statement
requires
companies to expense the value of employee stock options and similar
awards. Under FAS 123R, share-based payment awards result in a cost
that
will be measured at fair value on the awards’ grant date based on the
estimated number of awards that are expected to vest. Compensation
costs
for awards that vest will not be reversed if the awards expire without
being exercised. The Company uses historical data to estimate option
exercise and employee termination within the valuation model and
historical stock prices to estimate volatility.
|
Exhibit
No.
|
Description
of Exhibit
|
|
*3.1
|
Certificate
of Incorporation of the Company, as amended through March 8,
2007 (2006
10-KSB)
|
|
*3.2
|
Amended
Bylaws of the Company as presently in use (S-18 No. 2, Exhibit
3.2)
|
|
4.1
|
Certificate
of Incorporation of the Company, as amended (filed herewith as
Exhibit
3.1)
|
|
*10.3
|
1991
Stock
Option Plan (S-18 No. 3, Exhibit 10.1(a))
|
|
*10.3.1
|
Amendment
No.
1 to 1991 Stock Option Plan (1993 10-K)
|
|
*10.3.2
|
Amendment
No.
2 to 1991 Stock Option Plan (S-1)
|
|
*10.3.3
|
Amendment
No.
3 to 1991 Stock Option Plan (S-1)
|
|
*10.3.4
|
Amendment
No.
4 to 1991 Stock Option Plan (Option Plan S-8, Exhibit
4.5)
|
|
*10.3.5
|
Amendment
No.
5 to 1991 Stock Option Plan (1998 10-K/A, Exhibit
10.3.5)
|
|
*10.4
|
2002
Equity
Incentive Plan (2002 Proxy Statement)
|
|
*10.5
|
2002
Equity
Incentive Plan Form S-8 (Option Plan S-8)
|
|
*10.6
|
License
Agreement between ACIS, Inc. and the Company dated September
9, 1999 (1999
S-3)
|
|
*10.7
|
First
Amendment and Modification of ACIS, Inc. warrant agreement dated
September
7, 2001 (2001 10-Q, Exhibit 10.2)
|
|
*10.8
|
ACIS
Technology License Agreement between ACIS, Inc. and the Company
dated
September 27, 2001 (2001 10-Q, Exhibit 10.1)
|
|
*10.9
|
Triton
Business Development Services Engagement Agreement dated January
31, 2007
(2006 10-KSB)
|
|
21.1
|
Subsidiaries
of the Company
|
|
23.1
|
Consent
of
Marcum & Kliegman LLP
|
|
31.1
|
Rule
13a-14(a)/15d-14(a) Certification of Principal Executive
Officer
|
|
31.2
|
Rule
13a-14(a)/15d-14(a) Certification of Principal Financial
Officer
|
|
32.1(1)
|
Section
1350
Certifications
|
|
*
Previously
filed
|
||
(1)
In
accordance with Item 601(b)(32) of Regulation S-B, this Exhibit
is not
deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise
subject to the liabilities of that section. Such certifications
will not
be deemed incorporated by reference into any filing under the
Securities
Act or the Exchange Act, except to the extent that the registrant
specifically incorporates it by reference.
|
SIMTROL, INC. | ||
|
|
|
By: | /s/ Richard W. Egan | |
Date: March 28, 2008 |
Richard W. Egan, Chief Executive Officer |
Signature
|
Title
|
Date
|
||
/s/
Dallas S.
Clement
|
Chairman
of
the Board
|
March
28,
2008
|
||
Dallas S. Clement
|
||||
/s/
Richard
W. Egan
|
Chief
Executive Officer
|
March
28,
2008
|
||
Richard W. Egan
|
(Principal
Executive Officer)
|
|||
/s/
Stephen
N. Samp
|
Chief
Financial Officer
|
March
28,
2008
|
||
Stephen N. Samp
|
(Principal
Financial and
|
|||
Accounting
Officer)
|
||||
/s/
Adam D.
Senter
|
Director
|
March
28,
2008
|
||
Adam D. Senter
|
||||
/s/
Lee D.
Wilder
|
Director
|
March
28,
2008
|
||
Lee D. Wilder
|
Report
of Independent Registered Public Accounting Firm
|
F-1
|
Consolidated
Balance Sheet as of December 31, 2007
|
F-2
|
Consolidated
Statements of Operations for the Years Ended December 31, 2007
and
2006
|
F-4
|
Consolidated
Statements of Stockholders' Equity/(Deficiency) for the Years
Ended
December 31, 2007 and 2006
|
F-5
|
Consolidated
Statements of Cash Flows for the Years Ended December 31, 2007
and
2006
|
F-6
|
Notes
to Consolidated Financial Statements
|
F-7
|
CURRENT
ASSETS
|
||||
Cash
and cash equivalents
|
$
|
256,358
|
||
Certificate
of deposit
|
101,862
|
|||
Accounts
receivable, net
|
27,232
|
|||
Prepaid
expenses and other current assets
|
35,779
|
|||
Total
Current Assets
|
421,231
|
|||
LONG-TERM
ASSETS
|
||||
Property
and equipment, net
|
117,285
|
|||
Right
to license intellectual property
|
115,143
|
|||
Other
long-term assets
|
11,458
|
|||
TOTAL
ASSETS
|
$
|
665,117
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||
LIABILITIES
|
||||
CURRENT
LIABILITIES
|
||||
Accounts
payable
|
$
|
169,243
|
||
Accrued
expenses
|
126,903
|
|||
Deferred
revenue
|
462
|
|||
Common
stock to be issued
|
26,000
|
|||
Total
Current Liabilities
|
322,608
|
|||
Common
stock to be issued, less current portion
|
26,000
|
|||
Deferred
rent payable, less current portion
|
11,967
|
|||
TOTAL
LIABILITIES
|
360,575
|
|||
COMMITMENTS
AND CONTINGENCIES
|
||||
STOCKHOLDERS'
EQUITY
|
||||
Preferred
stock, $.00025 par value; 800,000 shares authorized;770,000 shares
of
Series A Convertible Preferred Stock designated; 728,664 outstanding;
liquidation value of $2,185,992; 4,700 shares of Series B Convertible
Preferred Stock designated and issued; liquidation value of
$3,525,000
|
183
|
|||
Common
stock, authorized 40,000,000 shares of $.001
par value; 7,314,371 shares issued and outstanding
|
7,314
|
|||
Additional
paid-in capital
|
72,119,986
|
|||
Accumulated
deficit
|
(71,822,941
|
)
|
||
Total
Stockholders’ Equity
|
304,542
|
|||
TOTAL
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$
|
665,117
|
2007
|
2006
|
||||||
Revenues:
|
|||||||
Software
licenses
|
$
|
97,584
|
$
|
159,659
|
|||
Service
|
93,469
|
65,033
|
|||||
Total
revenues
|
191,053
|
224,692
|
|||||
Cost
of revenues
|
|||||||
Software
licenses
|
2,834
|
3,873
|
|||||
Service
|
-
|
1,867
|
|||||
Total
cost of revenues
|
2,834
|
5,740
|
|||||
Gross
profit
|
188,219
|
218,952
|
|||||
Operating
expenses
|
|||||||
Selling,
general and administrative
|
2,956,697
|
1,502,983
|
|||||
Research
and development
|
828,564
|
416,982
|
|||||
Total
operating expenses
|
3,785,261
|
1,919,965
|
|||||
Loss
from operations
|
(3,597,042
|
)
|
(1,701,013
|
)
|
|||
Other
income/(expenses):
|
|||||||
Other
income/(expense)
|
42,825
|
(11,174
|
)
|
||||
Gain
on sale of intellectual property
|
-
|
250,000
|
|||||
Increased
fair value of warrants’ modification
|
(578,611
|
)
|
-
|
||||
Finance
expense on conversion of notes payable
|
(772,655
|
)
|
-
|
||||
Total
other income/(expense)
|
(1,308,441
|
)
|
238,826
|
||||
Net
loss
|
$
|
(4,905,483
|
)
|
$
|
(1,462,187
|
)
|
|
Dividend
on covenant default of convertible preferred stock
|
-
|
800,613
|
|||||
Preferred
stock dividend
|
599,917
|
-
|
|||||
Deemed
preferred dividend
|
939,118
|
-
|
|||||
Net
loss attributable to common stockholders
|
$
|
(6,444,518
|
)
|
$
|
(2,262,800
|
)
|
|
Net
loss per common share attributable to common stockholders-basic
and
diluted
|
$
|
(1.04
|
)
|
$
|
(0.52
|
)
|
|
Weighted
average number of common shares outstanding
|
6,204,921
|
4,349,737
|
Common stock
|
Preferred Stock
|
Additional
Paid-in
capital
|
Accumulated
deficit
|
Total
|
||||||||||||||||||
Number of
Shares
|
Par value
|
Number of
Shares
|
Par value
|
|||||||||||||||||||
Balance,
January 1, 2006
|
3,755,684
|
3,756
|
450,000
|
113
|
63,641,158
|
(63,916,236
|
)
|
(271,209
|
)
|
|||||||||||||
Net
Loss for the period
|
(1,462,187
|
)
|
(1,462,187
|
)
|
||||||||||||||||||
Conversion
of Series A Preferred Stock
|
261,336
|
261
|
(65,334
|
)
|
(17
|
)
|
(244
|
)
|
-
|
|||||||||||||
Dividend
payable on covenant default of convertible preferred stock
|
(800,613
|
)
|
(800,613
|
)
|
||||||||||||||||||
Issuance
of common stock to directors
|
87,984
|
88
|
36,012
|
36,100
|
||||||||||||||||||
Stock-based
compensation amortization
|
469,027
|
469,027
|
||||||||||||||||||||
Exercises
of stock options
|
625,000
|
625
|
249,375
|
250,000
|
||||||||||||||||||
Issuance
of common stock for purchase
|
200,000
|
200
|
51,800
|
52,000
|
||||||||||||||||||
Balance,
December 31, 2006
|
4,930,004
|
$
|
4,930
|
384,666
|
$
|
96
|
$
|
63,646,515
|
$
|
(65,378,423
|
)
|
$
|
(1,726,882
|
)
|
||||||||
Net
Loss for the period
|
(4,905,483
|
)
|
(4,905,483
|
)
|
||||||||||||||||||
Issuance
of Series B Preferred Stock
|
4,700
|
1 |
3,518,793
|
3,518,794
|
||||||||||||||||||
Conversion
of Series A Preferred Stock
|
162,672
|
163
|
(40,668)
|
|
(10 |
)
|
(153
|
)
|
-
|
|||||||||||||
Issuance
of Series A Preferred stock in modification
|
384,666
|
96
|
523,050
|
523,146
|
||||||||||||||||||
Issuance
of common stock to directors
|
18,431
|
18
|
21,432
|
21,450
|
||||||||||||||||||
Stock-based
compensation amortization
|
357,153
|
357,153
|
||||||||||||||||||||
Warrant
issued in Series A modification
|
245,620
|
245,620
|
||||||||||||||||||||
Issuance
of common stock for purchase of license agreement
|
100,000
|
100
|
25.900
|
26,000
|
||||||||||||||||||
Write
off remainder of previously accrued dividend payable
|
403,097
|
403,097
|
||||||||||||||||||||
Cashless
warrant exercises
|
713,387
|
713
|
(713
|
)
|
-
|
|||||||||||||||||
Warrants
issued for notes payable exchange
|
772,655
|
772,655
|
||||||||||||||||||||
Common
stock dividend on Series A and B Convertible Preferred
shares
|
604,977
|
605
|
599,312
|
(599,917
|
)
|
-
|
||||||||||||||||
Increase
in fair value of warrants due to modification
|
578,611
|
578,611
|
||||||||||||||||||||
Issuance
of common stock for services
|
784,900
|
785
|
489,596
|
490.381
|
||||||||||||||||||
Deemed
preferred dividend
|
939,118
|
(939,118
|
)
|
-
|
||||||||||||||||||
Balance,
December 31, 2007
|
7,314,371
|
7,314
|
733,364
|
183
|
72,119,986
|
(71,822,941
|
)
|
304,542
|
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
loss
|
$
|
(4,905,483
|
)
|
$
|
(1,462,187
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Gain
on sale of intellectual property
|
-
|
(250,000
|
)
|
||||
Depreciation
and amortization
|
80,080
|
9,733
|
|||||
Stock-based
compensation
|
378,603
|
505,127
|
|||||
Issuance
of stock for services
|
490,381
|
-
|
|||||
Issuance
of warrants in conversion of notes payable to preferred
stock
|
772,655
|
-
|
|||||
Increase
in fair value of warrants’ modification
|
578,611
|
-
|
|||||
Note
interest exchanged into offering
|
5,736
|
||||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable
|
57,137
|
(81,476
|
)
|
||||
Prepaid
expenses and other current assets
|
(4,471
|
)
|
1,922
|
||||
Other
long-term assets
|
(11,458
|
)
|
-
|
||||
Interest
payable
|
-
|
8,351
|
|||||
Accounts
payable
|
(98,836
|
)
|
117,010
|
||||
Accrued
expenses
|
4,625
|
9,693
|
|||||
Deferred
revenue
|
462
|
(19,144
|
)
|
||||
Deferred
rent payable, less current portion
|
11,967
|
-
|
|||||
Net
cash used in operating activities
|
(2,639,991
|
)
|
(1,160,971
|
)
|
|||
Cash
flows from/(used in) investing activities:
|
|||||||
Purchases
of property and equipment and leasehold improvements
|
(125,677
|
)
|
(5,200
|
)
|
|||
Proceeds
from sale of intellectual property
|
-
|
250,000
|
|||||
Net
cash provided by/(used in) investing activities
|
(125,677
|
)
|
244,800
|
||||
Cash
flows from /(used in) financing activities:
|
|||||||
Increase
in certificate of deposit
|
(100,000
|
)
|
-
|
||||
Net
proceeds from exercise of stock options
|
-
|
250,000
|
|||||
Proceeds
from notes payable issuance
|
331,000
|
416,000
|
|||||
Repayment
of note payable
|
(14,286
|
)
|
(37,000
|
)
|
|||
Deposit
returned from cancelled offering
|
-
|
(12,000
|
)
|
||||
Cash
overdraft
|
(1,420
|
)
|
1,420
|
||||
Net
proceeds from stock issuances
|
2,808,594
|
-
|
|||||
Net
cash provided by financing activities
|
3,023,888
|
618,420
|
|||||
Increase/(decrease)
in cash and cash equivalents
|
258,220
|
(297,751
|
)
|
||||
Cash
and cash equivalents, beginning of the year
|
0
|
297,751
|
|||||
Cash
and cash equivalents, end of the year
|
$
|
258,220
|
$
|
0
|
|||
Supplementary
disclosure:
|
|||||||
Interest
paid
|
$
|
3,085
|
$
|
213
|
|||
Income
taxes paid
|
$
|
-
|
$
|
-
|
|||
Supplemental
schedule of non cash investing and financing activities:
|
|||||||
Non
cash investing and financing activities:
|
|||||||
Supplemental
schedule of non-cash investing and financing activities:
|
|||||||
Dividend
payable on covenant default of convertible preferred stock
|
$
|
-
|
$
|
800,613
|
|||
Issuance
of common stock in acquisition of JDS interest
|
$
|
26,000
|
$
|
$
52,000
|
|||
Exchange
of notes payable for Series B Preferred stock
|
$
|
710,200
|
$
|
-
|
|||
Common
stock dividend paid
|
$
|
599,917
|
$
|
-
|
|||
Issuance
of Series A Preferred stock as dividend payment on covenant
default
|
$
|
768,766
|
$
|
-
|
|||
Issuance
of warrants as dividend payment on covenant default
|
$
|
403,097
|
$
|
-
|
|||
Deferred
offering costs
|
$
|
16,600
|
$
|
-
|
|||
Deemed
preferred dividend
|
$
|
939,118
|
$
|
-
|
December 31, 2007
|
December 31, 2006
|
||||||
Options
|
4,401,375
|
1,775,025
|
|||||
Warrants
|
16,434,774
|
4,897,737
|
|||||
Convertible
Preferred Stock
|
12,314,656
|
1,538,664
|
|||||
Total
|
33,150,805
|
8,211,426
|
|
2007
|
2006
|
|||||
Assumptions
|
|
|
|||||
Risk-free
rate
|
3.32%-4.97
|
%
|
4.88-4.92
|
%
|
|||
Annual
rate of dividends
|
0
|
0
|
|||||
Volatility
|
89-133
|
%
|
90-148
|
%
|
|||
Average
life
|
5
years
|
2.9
years
|
Weighted-
Average |
Weighted-Average
Remaining |
Aggregate
|
|||||||||||
Options
|
Shares
|
Exercise Price
|
Term
|
Intrinsic Value
|
|||||||||
Outstanding
January 1, 2007
|
1,775,025
|
$
|
1.40
|
||||||||||
Granted
|
2,904,600
|
$
|
0.72
|
||||||||||
Exercised
|
-
|
$
|
-
|
||||||||||
Terminated
|
(278,250
|
)
|
$
|
1.56
|
|||||||||
Outstanding
at December 31, 2007
|
4,401,375
|
$
|
0.94
|
7.7
|
$
|
1,404,056
|
|||||||
Exercisable
at December 31, 2007
|
1,367,025
|
$
|
1.42
|
4.6
|
$
|
1,143,529
|
Options Outstanding
|
Options Exercisable
|
|||||||||||||||
|
|
Weighted
|
|
|
|
|||||||||||
|
|
Average
|
Weighted
|
|
Weighted
|
|||||||||||
Range of
|
Number
|
Remaining
|
Average
|
Number
|
Average
|
|||||||||||
Exercise
|
Outstanding at
|
Contractual
|
Exercise
|
Exercisable at
|
Exercise
|
|||||||||||
Price
|
December 31, 2007
|
Life (Years)
|
Price
|
December 31, 2007
|
Price
|
|||||||||||
$0.26-$0.48
|
2,066,000
|
6.89
|
$
|
0.39
|
738,750
|
$
|
0.40
|
|||||||||
$0.55-$0.90
|
1,254,600
|
8.56
|
$
|
0.76
|
325,000
|
$
|
0.69
|
|||||||||
$1.04-$2.00
|
955,000
|
8.90
|
$
|
1.39
|
177,500
|
$
|
1.96
|
|||||||||
$2.25-$2.50
|
65,300
|
3.89
|
$
|
2.30
|
65,300
|
$
|
2.30
|
|||||||||
$3.50-$4.80
|
32,150
|
2.48
|
$
|
4.31
|
32,150
|
$
|
4.31
|
|||||||||
$9.10-$55.00
|
28,325
|
2.53
|
$
|
27.73
|
28,325
|
$
|
27.73
|
|||||||||
4,401,375
|
7.69
|
$
|
0.94
|
1,367,025
|
$
|
1.42
|
Year Ended
|
Year Ended
|
||||||
December 31, 2007
|
December 31, 2006
|
||||||
Expected
Statutory Rate
|
(34.00
|
)%
|
(34.00
|
)%
|
|||
State
income tax rate, net of federal benefit
|
(3.96
|
)%
|
(3.96
|
)%
|
|||
(37.96
|
)%
|
(37.96
|
)%
|
||||
Permanent
Difference
|
(10.45
|
)%
|
-
|
||||
Valuation
Allowance
|
(27.51
|
)%
|
(37.96
|
)%
|
|||
Net
Actual Rate
|
0.00
|
%
|
0.00
|
%
|
Machinery
and equipment
|
$
|
130,078
|
||
Furniture
and fixtures
|
6,619
|
|||
Leasehold
improvements
|
15,840
|
|||
152,537
|
||||
Less
accumulated depreciation and amortization
|
(35,252
|
)
|
||
$
|
117,285
|
January
31, 2007-
|
1,400,000
|
|||
March
14, 2007 -
|
200,000
|
|||
April
10, 2007 –
|
75,000
|
|||
May
30, 2007 –
|
75,000
|
|||
June
25, 2007 -
|
75,000
|
|||
August
6, 2007 -
|
25,000
|
|||
August
11, 2007 -
|
150,000
|
|||
August
14, 2007 -
|
5,000
|
|||
August
22, 2007 -
|
35,000
|
|||
September
1, 2007 -
|
25,000
|
|||
October
4, 2007 -
|
35,000
|
|||
October
10, 2007 -
|
25,000
|
|||
October
22, 2007 –
|
50,000
|
|||
December
11, 2007 –
|
729,600
|
Date
|
Number of shares
|
|||
January
31, 2007
|
11,200
|
|||
February
28, 2007
|
26,700
|
|||
March
31, 2007
|
26,700
|
|||
April
30, 2007
|
26,700
|
|||
May
31, 2007
|
26,700
|
|||
June
30, 2007
|
26,700
|
|||
July
31, 2007
|
26,700
|
|||
August
31, 2007
|
26,700
|
|||
September
30, 2007
|
26,700
|
|||
October
31, 2007
|
26,700
|
|||
November
30, 2007
|
26,700
|
|||
December
31, 2007
|
26,700
|
·
|
The
Series B Preferred Stock stated value is $750.00 and each share
converts
into common stock at the conversion price of $0.375 at any time
and
without limitation.
|
·
|
Without
approval of a majority of the Series B Preferred Stock Holders,
the
Company shall not incur debt (other than debt collateralized
by accounts
receivable of the Company) in excess of an aggregate of $1.5
million
outside of trade debt in the normal course of business. The terms
of such
debt shall not encumber any copyrights, marketing materials,
software code
or any other proprietary technology, software or product processes,
patents or patent licenses.
|
·
|
The
Series B Preferred Stock will pay a 12% (based on stated value)
noncumulative coupon, payable semi-annually (June 30, December
31) in cash
or common stock (common stock value deemed $0.375 for purpose
of dividend
payment if closing price of common stock on payment date is less
than
$0.375).
|
·
|
If
the Company has a current registration statement on file covering
those
common shares represented by Series B Preferred Stock and the
Company’s
common stock bid price closes at or above $1.00 for 20 consecutive
trading
days and the average daily trading volume of the common stock
is equal to
or greater than $150,000, then Series B Preferred Stock will
automatically
convert to common at $0.375 per common
share.
|
·
|
Series
B Preferred Stock Holders receive pre-emptive right to participate
in
subsequent equity rounds at the same pro rata percentage of ownership
they
currently own in Company on an as-converted basis
today.
|
·
|
Series
B Preferred Stock callable at $1,875 per share at option of
Company.
|
·
|
A
total of 4,700 shares of Series B Preferred Stock were
designated.
|
·
|
The
Company was required to file a registration statement within
sixty (60)
days of the closing of this Offering and use its best efforts
for it to be
effective within sixty (60) days from its filing. In the event
that these
filing requirements were not met, the Company will pay the Investor
(pro
rated on a daily basis), as partial compensation for such failure,
and not
as a penalty, in the form of common stock, equal to one and one
half
percent (1.5%) of the purchase price of the registrable securities
purchased from the Company and held by the Investor for each
month (or
portion thereof) until such Registration Statement has been filed.
The
Company filed a resale registration statement on Form SB-2 on
May 14, 2007
to register the common stock underlying the Series B Convertible
Preferred
Stock, the common stock underlying the warrants issued in conjunction
with
the exchange of the notes payable, and the common stock underlying
the
warrants in the private placement. As of March 28, 2008, the
registration
statement has not been declared effective by the
SEC
|
2007
|
2006
|
||||||
Warrants
outstanding at beginning of year
|
4,897,737
|
4,937,880
|
|||||
Granted
|
12,560,865
|
-
|
|||||
Exercised
|
(927,828
|
)
|
-
|
||||
Terminated
|
(96,000
|
)
|
(40,143
|
)
|
|||
Warrants
outstanding at December 31
|
16,434,774
|
4,897,737
|
·
|
Two
Hundred Thousand (200,000) restricted common shares of the Company's
capital stock to IDS on November 28,
2006;
|
·
|
One
Hundred Thousand (100,000) restricted common shares of the Company's
capital stock to IDS on November 22,
2007;
|
·
|
One
Hundred Thousand (100,000) restricted common shares of the Company's
capital stock to IDS on November 22, 2008;
and
|
·
|
One
Hundred Thousand (100,000) restricted common shares of the Company's
capital stock to IDS on November 22,
2009.
|
· |
The
Convertible Notes are unsecured, bear interest at the rate of
12% per
annum, are payable six months from the issue date (“Maturity Date”) and
can be pre-paid at any time without penalty.
|
· |
If
Simtrol closes a “Qualifying Next Equity Financing” before the Maturity
Date, the then outstanding balance of principal and accrued interest
on
the Convertible Notes will automatically convert into shares
of the “Next
Equity Financing Securities” we issue. If we close a “Non-Qualifying Next
Equity Financing” before the Maturity Date, the then-outstanding balance
of principal and accrued interest on the Convertible Notes can
be
converted, at the option and election of the investor, into shares
of the
“Next Equity Financing Securities” we issue.
|
·
|
A
“Qualifying Next Equity Financing” means the first bona fide equity
financing (or series of related equity financing transactions)
occurring
subsequent to the date of issue of a Convertible Note in which
we sell and
issue any of our securities for total consideration totaling
not less than
$2.0 million in the aggregate (including the principal balance
and accrued
but unpaid interest to be converted on all our outstanding Convertible
Notes) at a
|
· |
price
per share for equivalent shares of common stock that is not greater
than
$0.75 per share. A “Non-Qualifying Next Equity Financing” means that we
complete a bona fide equity financing but we fail to raise total
consideration of at least $2.0 million, or the price per share
for
equivalent shares of common stock is greater than $0.75 per share.
“Next
Equity Financing Securities” means the type and class of equity securities
that we sell in a Qualifying Next Equity Financing or a Non-Qualifying
Next Equity Financing. If we sell a unit comprising a combination
of
equity securities, then the Next Equity Financing Securities
shall be
deemed to constitute that unit.
|
· |
Upon
conversion of a Convertible Note, we will issue that number of
shares of
Next Equity Financing Securities equal the quotient obtained
by dividing
the then outstanding balance of principal and accrued interest
on the
Convertible Notes by the price per share of the Next Equity Financing
Securities.
|
· |
Upon
any default, Simtrol would be required to pay a 1% default fee
on the
outstanding balance. The default fee will be added to the outstanding
balance and become due under the terms of the Convertible Note.
|
January
31, 2008 –
|
26,700
|
|||
February
29, 2008 –
|
26,700
|
Three Months
Ended June 30, 2007
|
Six
Months
Ended June 30, 2007
|
Nine
Months
Ended September 30, 2007
|
||||||||
Net
loss- previously reported
|
$
|
(881,575
|
)
|
$
|
(2,427,856
|
)
|
$
|
(3,982,557
|
)
|
|
Deemed
preferred dividend – previously reported
|
-
|
939,118
|
939,118
|
|||||||
Net
loss attributable to common stockholders – previously
reported
|
$
|
(881,575
|
)
|
$
|
(3,366,974
|
)
|
$
|
(4,921,675
|
)
|
|
Preferred
dividend
|
(300,936
|
)
|
(300,936
|
)
|
(300,936
|
)
|
||||
Net
loss attributable to common stockholders, as restated
|
$
|
(1,182,511
|
)
|
$
|
(3,667,910
|
)
|
$
|
(5,222,611
|
)
|
|
Net
loss per common share, basic and diluted -previously
reported
|
$
|
(0.14
|
)
|
$
|
(0.59
|
)
|
$
|
(0.82
|
)
|
|
Net
loss per common share, basic and diluted, as restated
|
$
|
(0.19
|
)
|
$
|
(0.64
|
)
|
$
|
(0.87
|
)
|
|
Weighted
average shares outstanding, basic and diluted – previously
reported
|
6,121,893
|
5,709,351
|
6,006,936
|